Call for Papers

Article List

Editorial [Hot Topic: Alzheimer Drug Design Based on the Amyloid Hypothesis (Executive Editors: D. Munoz-Torrero and P. Camps)]
[ Vol. 12 , Issue. 33 ]
Author(s): Diego Munoz-Torrero and Pelayo Camps
Pages: 4281-4282 (2)
Vaccine Development for Alzheimers Disease
[ Vol. 12 , Issue. 33 ]
Author(s): Kevin A. DaSilva, Isabelle Aubert and JoAnne McLaurin
Pages: 4283-4293 (11)
Views on Amyloid Hypothesis and Secretase Inhibitors for Treating Alzheimers Disease: Progress and Problems
[ Vol. 12 , Issue. 33 ]
Author(s): Jeffrey-Tri Nguyen, Abdellah Yamani and Yoshiaki Kiso
Pages: 4295-4312 (18)
Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
[ Vol. 12 , Issue. 33 ]
Author(s): Chewki Ziani-Cherif, Bachir Mostefa-Kara and Fatima Z. Brixi-Gormat
Pages: 4313-4335 (23)
Selective Modulation of Aβ42 Production in Alzheimers Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
[ Vol. 12 , Issue. 33 ]
Author(s): Stefanie Leuchtenberger, Dirk Beher and Sascha Weggen
Pages: 4337-4355 (19)
The Development of Preventives and Therapeutics for Alzheimers Disease that Inhibit the Formation of β-Amyloid Fibrils (fAβ), as Well as Destabilize Preformed fAβ
[ Vol. 12 , Issue. 33 ]
Author(s): Kenjiro Ono, Hironobu Naiki and Masahito Yamada
Pages: 4357-4375 (19)
Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors
[ Vol. 12 , Issue. 33 ]
Author(s): Ana Castro and Ana Martinez
Pages: 4377-4387 (11)
Molecular and Biochemical Features in Alzheimers Disease
[ Vol. 12 , Issue. 33 ]
Author(s): Merce Pallas and Antoni Camins
Pages: 4389-4408 (20)